Experiment 362123

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationPRENDIVILLE,J: CROWTHER,D: THATCHER,N: WOLL,PJ: FOX,BW: MC GOWN,A: TESTA,N: STERN,P: MCDERMOTT,R: POTTER,M: PETTIT,GR:. (1993). A PHASE I STUDY OF INTRAVENOUS BRYOSTATIN 1 IN PATIENTS WITH ADVANCED CANCER.. 68(2)
Amount utilized
Compound isolated
DiseasePHASE I STUDY IN 19 PATIENTS WITH ADVANCED SOLID TUMORS. DOSES OF 5-65 MICROGRAM/SQUARE METER WERE USED. NO ANTITUMOR EFFECT SEEN. SIDE-EFFECTS INCLUDED MYALGIA, FLU-LIKE SYMPTOMS, HYPOTENSION, CELLULITIS AND THROMBOPHLEBITIS, DECREASES IN PLATELETS, LEUKOCYTES AND RBC'S.
Dose amountVAR
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE